Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 6.973B
March 31, 2026 6.722B
December 31, 2025 6.811B
September 30, 2025 6.802B
June 30, 2025 6.967B
March 31, 2025 6.588B
December 31, 2024 6.518B
September 30, 2024 6.76B
June 30, 2024 7.822B
March 31, 2024 7.963B
December 31, 2023 8.139B
September 30, 2023 8.21B
June 30, 2023 8.376B
March 31, 2023 8.289B
December 31, 2022 8.202B
September 30, 2022 8.203B
June 30, 2022 8.461B
Date Value
March 31, 2022 8.639B
December 31, 2021 8.97B
September 30, 2021 8.883B
June 30, 2021 8.853B
March 31, 2021 8.981B
December 31, 2020 9.217B
September 30, 2020 8.893B
June 30, 2020 3.224B
March 31, 2020 3.066B
December 31, 2019 3.439B
September 30, 2019 3.336B
June 30, 2019 3.591B
March 31, 2019 3.551B
December 31, 2018 3.759B
September 30, 2018 4.074B
June 30, 2018 990.80M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 11.93B
Eli Lilly & Co. 108.40B
ANI Pharmaceuticals, Inc. 896.90M
EyePoint, Inc. 61.78M
Amylyx Pharmaceuticals, Inc. 25.40M

Total Liabilities (Quarterly) Related Metrics